Deal Alert: Aarin, Accel, IDG & Kitven invest Rs.27.5 Cr in biopharma co Theramyt
Aarin Capital, Accel Partners, IDG Ventures as well as Karnataka state government-backed KITVEN have invested INR 27.5 crore in Bangalore-based biopharma company Theramyt Novobiologics. Theramyt is developing therapies for cancer,…